Maria A Lehn - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Maria A Lehn

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancers|March 13, 2024

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell CarcinomaAmeet A Chimote, Maria A Lehn, Jay Bhati, et al.

Journal for Immunotherapy of Cancer|November 3, 2022

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.

JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026

Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancers|March 13, 2024

Proton Treatment Suppresses Exosome Production in Head and Neck Squamous Cell CarcinomaAmeet A Chimote, Maria A Lehn, Jay Bhati, et al.

Journal for Immunotherapy of Cancer|November 3, 2022

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibitionMcKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.

JAMA Otolaryngology-- Head & Neck Surgery|February 26, 2026

Amivantamab for Recurrent or Metastatic Adenoid Cystic Carcinoma: A Phase 2 Nonrandomized Clinical TrialGlenn J Hanna, Olga Y Zamulko, Punita Grover, et al.

Pageof 2